Aurora Cannabis Inc. (ACB)
USD 4.84
(1.89%)
USD 4.84
(1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 186.37 Million CAD | 44.68% |
| 2022 | 128.82 Million CAD | -7.93% |
| 2021 | 139.92 Million CAD | 1.6% |
| 2020 | 137.72 Million CAD | -12.43% |
| 2019 | 157.26 Million CAD | -4.96% |
| 2018 | 165.47 Million CAD | 282.92% |
| 2017 | 43.21 Million CAD | 266.51% |
| 2016 | 11.79 Million CAD | 183.28% |
| 2015 | 4.16 Million CAD | 16281.3% |
| 2014 | 25.4 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | 186.37 Million CAD | 29.47% |
| 2023 FY | 186.37 Million CAD | 44.68% |
| 2023 Q1 | 139.22 Million CAD | -0.5% |
| 2023 Q2 | 143.95 Million CAD | 3.4% |
| 2022 Q4 | 139.92 Million CAD | 8.62% |
| 2022 Q3 | 128.82 Million CAD | 5.08% |
| 2022 Q2 | 122.59 Million CAD | -16.17% |
| 2022 FY | 128.82 Million CAD | -7.93% |
| 2022 Q1 | 146.24 Million CAD | 4.51% |
| 2021 Q1 | 155.81 Million CAD | 13.14% |
| 2021 Q2 | 149.53 Million CAD | -4.04% |
| 2021 Q3 | 129.9 Million CAD | -13.13% |
| 2021 Q4 | 139.92 Million CAD | 7.72% |
| 2021 FY | 139.92 Million CAD | 1.6% |
| 2020 Q4 | 137.72 Million CAD | 12.05% |
| 2020 Q3 | 122.91 Million CAD | -38.79% |
| 2020 Q2 | 200.81 Million CAD | 8.71% |
| 2020 Q1 | 184.73 Million CAD | 17.47% |
| 2020 FY | 137.72 Million CAD | -12.43% |
| 2019 Q2 | 251.16 Million CAD | 24.03% |
| 2019 Q1 | 202.49 Million CAD | 22.37% |
| 2019 FY | 157.26 Million CAD | -4.96% |
| 2019 Q3 | 281.76 Million CAD | 12.18% |
| 2019 Q4 | 157.26 Million CAD | -44.19% |
| 2018 Q3 | 134.9 Million CAD | 40.73% |
| 2018 FY | 165.47 Million CAD | 282.92% |
| 2018 Q4 | 165.47 Million CAD | 22.66% |
| 2018 Q2 | 95.86 Million CAD | 12.31% |
| 2018 Q1 | 85.35 Million CAD | 97.51% |
| 2017 Q3 | 32.36 Million CAD | 52.79% |
| 2017 Q4 | 43.21 Million CAD | 33.54% |
| 2017 FY | 43.21 Million CAD | 266.51% |
| 2017 Q1 | 17.73 Million CAD | 50.42% |
| 2017 Q2 | 21.18 Million CAD | 19.42% |
| 2016 Q4 | 11.79 Million CAD | 35.63% |
| 2016 Q1 | 3.1 Million CAD | -25.45% |
| 2016 Q2 | 5.71 Million CAD | 84.28% |
| 2016 Q3 | 8.69 Million CAD | 52.03% |
| 2016 FY | 11.79 Million CAD | 183.28% |
| 2015 FY | 4.16 Million CAD | 16281.3% |
| 2015 Q3 | 8.17 Million CAD | 153.87% |
| 2015 Q1 | 314.35 Thousand CAD | 1137.19% |
| 2015 Q2 | 3.21 Million CAD | 923.82% |
| 2015 Q4 | 4.16 Million CAD | -49.06% |
| 2014 Q4 | 25.4 Thousand CAD | 0.0% |
| 2014 FY | 25.4 Thousand CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | -100.0% |
| 2009 Q2 | 1500.00 CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | -67.61% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -2653.376% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -476.444% |
| Cosmos Health Inc. | 4.78 Million USD | -3791.708% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -73174.832% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -184.01% |
| Cronos Group Inc. | 30.33 Million USD | -514.312% |
| Incannex Healthcare Limited | -10.01 Million USD | 1960.969% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -366.185% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 122091.386% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -3149.938% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -3149.938% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -9868.513% |
| Theratechnologies Inc. | 6.06 Million USD | -2972.47% |
| Alpha Teknova, Inc. | 11.59 Million USD | -1507.521% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -5474.669% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -78.601% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -6754.579% |
| Dynavax Technologies Corporation | 53.29 Million USD | -249.739% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -18637599900.0% |
| Radius Health, Inc. | 278.64 Million USD | 33.113% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -22916.288% |
| Alvotech | 74.43 Million USD | -150.394% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -1500.206% |
| SIGA Technologies, Inc. | 64.21 Million USD | -190.222% |
| Shineco, Inc. | 1.58 Million USD | -11632.645% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Journey Medical Corporation | 10.2 Million USD | -1726.141% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -11473.338% |
| Embecta Corp. | 152.1 Million USD | -22.535% |
| Harrow Health, Inc. | 10.86 Million USD | -1615.064% |
| Procaps Group, S.A. | 96.83 Million USD | -92.472% |
| Biofrontera Inc. | 10.9 Million USD | -1608.618% |
| DURECT Corporation | 2.21 Million USD | -8299.099% |
| PainReform Ltd. | - USD | -Infinity% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -140.771% |
| OptiNose, Inc. | 8.05 Million USD | -2214.655% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -3170.309% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -559.668% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -3943.423% |
| ProPhase Labs, Inc. | 3.84 Million USD | -4752.278% |
| Phibro Animal Health Corporation | 265.91 Million USD | 29.91% |
| Procaps Group S.A. | 96.83 Million USD | -92.472% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 94.628% |
| Rockwell Medical, Inc. | 5.87 Million USD | -3074.519% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -1375.311% |
| Tilray Brands, Inc. | 252.08 Million USD | 26.067% |
| PetIQ, Inc. | 159.3 Million USD | -16.99% |
| Talphera, Inc. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -386.621% |
| Alimera Sciences, Inc. | 1.87 Million USD | -9818.893% |
| Assertio Holdings, Inc. | 37.68 Million USD | -394.55% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -1695.53% |
| Hempacco Co., Inc. | 2.54 Million USD | -7230.054% |
| Alvotech | 74.43 Million USD | -150.394% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -191.081% |
| Kamada Ltd. | 87.74 Million USD | -112.402% |
| Currenc Group, Inc. | 732.91 Thousand USD | -25329.554% |
| Indivior PLC | 141.79 Million USD | -31.436% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -38580.06% |
| Flora Growth Corp. | 8.5 Million USD | -2090.597% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -73174.832% |
| Evolus, Inc. | 10.99 Million USD | -1594.635% |
| HUTCHMED (China) Limited | 50.25 Million USD | -270.838% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -76.104% |
| Akanda Corp. | 1.28 Million USD | -14382.623% |